OncoSec Medical Inc (ONCSQ)

[Titan V]

Not sure if we will see additional data from the current trial. I think it has served its purpose and it is now up to the registration trial to prove things conclusively once and for all on patients who are all actual nonresponders. As to the market's reaction to the last data set, I suppose it wanted more confidence from results from more than just 9 actual nonresponders.

RE: TNBC data, it's only 10 patients, phase I, and a monotherapy. I would not expect it to do anything significant at this stage. Data-wise, interim data from the melanoma registration trial in Q4 may be the only significant event for 2017 and it will be make or break data for the company.